SCHEMBL4002255

SCHEMBL4002255

CNC(=O)Cc1ccc2oc(-c3ccc(O)c(OC)c3)c(SC)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 8/20 0.47
CSNK2B P67870 8/20 0.47
CSNK2A1 P68400 8/20 0.47
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 2/20 0.42
CYP3A4 P08684 2/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
MAPK1 P28482 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
ALOX15 P16050 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GAA P10253 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4008540 0.90 CSNK2A2 (0.48) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL4001838 0.90 CSNK2A2 (0.46) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL3002368 0.90 CSNK2A2 (0.48) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL3001735 0.89 ALDH1A1 (0.55) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL3001522 0.88 CSNK2A2 (0.48) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL17667809 0.88 HSD17B10 (0.48) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL17667816 0.87 TRPV1 (0.46) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL3007864 0.86 CSNK2A2 (0.47) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL3000828 0.84 CSNK2A2 (0.47) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL17667813 0.84 CSNK2A2 (0.41) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069321-B1 NOVEL BENZOFURAN TYPE DERIVATIVES, A COMPOSITION COMPRISING THE SAME FOR TREATING OR PREVENTING COGNITIVE DYSFUNCTION AND THE USE THEREOF MEDIFRON DBT CO LTD (KR) 2016-04-13 EP claimed
EP-2069321-A1 NOVEL BENZOFURAN TYPE DERIVATIVES, A COMPOSITION COMPRISING THE SAME FOR TREATING OR PREVENTING COGNITIVE DYSFUNCTION AND THE USE THEREOF Digital Biotech Co., Ltd. (KR) 2009-06-17 EP disclosed
WO-2008041826-A1 NOVEL BENZOFURAN TYPE DERIVATIVES, A COMPOSITION COMPRISING THE SAME FOR TREATING OR PREVENTING COGNITIVE DYSFUNCTION AND THE USE THEREOF DIGITAL BIOTECH CO., LTD (KR) 2008-04-10 WO disclosed